World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Netherlands
2026
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Microbiology

D-Index
116
Citations
66715
World Ranking
176
National Ranking
10

Medicine

D-Index
117
Citations
67800
World Ranking
4133
National Ranking
159

Research.com Recognitions

  • 2026 - Research.com Microbiology in Netherlands Leader Award
  • 2025 - Research.com Microbiology in Netherlands Leader Award
  • 2023 - Research.com Medicine in Netherlands Leader Award

Overview

Peter Reiss is affiliated with the University of Amsterdam in the Netherlands and has contributed extensively to the field of medicine, with a specific focus on infectious diseases. Their research covers a range of topics related to HIV/AIDS and its complications.

The scientist's main fields of study include medicine, with significant attention to the subfields of infectious diseases, epidemiology, emergency medicine, virology, and physiology. This multidisciplinary approach reflects an engagement with both the clinical and biological aspects of disease.

Peter Reiss's research topics involve various aspects of HIV/AIDS, including research and interventions, treatment complications, drug development, and co-infections. The main topics of their work are:

  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS drug development and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Hepatitis C virus research

The scientist has published numerous papers in respected venues. Recent publications include:

  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk, 2020, Circulation
  • HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases, 2020, Nature Communications
  • Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV, 2021, Nature Communications
  • Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies, 2024, The Lancet HIV
  • Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society-USA Panel, 2020, UNC Libraries

Peter Reiss frequently collaborates with several researchers including Marc van der Valk, Ferdinand W.N.M. Wit, Neeltje A. Kootstra, Ard van Sighem, and Anders Boyd. These collaborations indicate a broad network within the HIV research community.

The scientist's work has been published regularly in venues such as The Journal of Infectious Diseases, Clinical Infectious Diseases, AIDS, The Lancet HIV, and UNC Libraries, with multiple publications in each. This highlights sustained contributions to journals focused on infectious diseases and HIV/AIDS.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Combination antiretroviral therapy and the risk of myocardial infarction

    Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Class of antiretroviral drugs and the risk of myocardial infarction.

    Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Decline in the AIDS and death rates in the EuroSIDA study: an observational study

    A Mocroft;B Ledergerber;C Katlama;O Kirk

  • Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

    Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss

  • Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

    Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut

  • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

    Caroline Sabin;Signe Westring Worm;Rainer Weber

  • Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

    Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat

  • Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

    Kees Brinkman;Jan A Smeitink;Johannes A Romijn;Peter Reiss

  • A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

    Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella

  • Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.

    Graeme Meintjes;Stephen D Lawn;Stephen D Lawn;Fabio Scano;Gary Maartens

  • Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study

    Judith Schouten;Ferdinand W. Wit;Ineke G. Stolte;Neeltje A. Kootstra

  • Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

    Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies

    J Gill;Margaret T May;C Lewden;M Saag

  • Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

    Stéphane De Wit;Caroline Sabin;Rainer Weber;Signe Westring Worm

  • Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

    Smith C;Sabin Ca;Lundgren Jd

  • Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

    Marieke Den Brinker;Ferdinand W.N.M. Wit;Pauline M.E. Wertheim-van Dillen;Suzanne Jurriaans

Frequent Co-Authors

Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Caroline Sabin
Caroline Sabin University College London
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Andrew N. Phillips
Andrew N. Phillips University College London
Amanda Mocroft
Amanda Mocroft University College London
Rainer Weber
Rainer Weber University of Zurich
Wafaa El-Sadr
Wafaa El-Sadr Columbia University
Matthew Law
Matthew Law University of New South Wales
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Stéphane De Wit
Stéphane De Wit Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to various healthcare and research careers, but expanding your skill set with related qualifications can enhance job prospects. For example, the professional coder certification offers a pathway into medical coding, a critical role in healthcare documentation and billing. This credential is in high demand and can be pursued through accelerated programs.

For those interested in managing healthcare data, becoming a health information manager is a rewarding career with strong salary potential. Detailed insights into the health information manager salary and career paths can help guide your decision on whether to specialize in this field.

To equip yourself with formal education, consider enrolling in one of the best cahiim accredited him programs online. These programs ensure quality training and prepare students for certification, which is essential for advancing in health information management roles.

Finally, if you are looking for quick entry into healthcare administration, exploring the fastest online medical billing and coding certificate programs can be an excellent starting point. These programs provide foundational skills useful alongside a microbiology background.

Best Scientists Citing Peter Reiss

Trending Scientists

Recently Published Articles